Discontinuation report MYLAN-BUPROPION XL
Report ID | 167819 |
Drug Identification Number | 02382083 |
Brand name | MYLAN-BUPROPION XL |
Common or Proper name | Bupropion |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
Strength(s) | 300MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 90BT, 100BT |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-08-18 |
Remaining supply date | 2022-08-18 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Last lot 3107588, Expiry Dec-31-2021 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-08-25 | French | Compare |
v1 | 2022-08-25 | English | Compare |
Showing 1 to 2 of 2